Get the free weekly funding digest
The latest funding rounds, like Violet Therapeutics’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
New funding rounds, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Violet Therapeutics Raises $4.75M in Seed Extension Funding from Dementia Discovery Fund and others to advance its EphB3-targeting small molecule program.
Amount Raised
$4.75 Million
Round Type
seed
CambridgeOtherInvestors
Description
Violet Therapeutics, a Somerville, MA-based preclinical-stage biotechnology company, raised $4.75M in Seed extension funding. Backers included Dementia Discovery Fund, UTEC, Ono Venture Investment, and Mass General Brigham Ventures. The company intends to use the funds to support advancement of its lead small molecule program targeting EphB3 through key IND-enabling activities. Led by CEO Meredith Fisher, Violet Therapeutics is focused on developing therapies for neurodegenerative diseases.
Funding Insights
Based on industry dataWatching Violet Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan